Combination Chemotherapy in Treating Patients With Colorectal Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Giving drugs at the time of day that allows for the best drug
response may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor
cells.
PURPOSE: Randomized phase II trial to determine the best time to give irinotecan combined
with fluorouracil, leucovorin, and oxaliplatin in treating patients who have colorectal
cancer.
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC